14/03/2019 22:34:21

Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Maxar Technologies Ltd. (MAXR)

LOS ANGELES, March 14, 2019 (GLOBE NEWSWIRE) --

Glancy Prongay & Murray LLP

(“GPM”) reminds investors of the March 15, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Maxar Technologies Ltd. (“Maxar” or the “Company”) (NYSE: MAXR) securities between March 29, 2018 and January 7, 2019, inclusive (the “Class Period”).

If you are a shareholder who suffered a loss, click here to participate.

On August 7, 2018, Spruce Point Capital published a report claiming that Maxar “has pulled one of the most aggressive accounting schemes Spruce Point has ever seen to inflate Non-IFRS earnings by 79%,” and that the Company’s “$3.7 billion of rising debt with almost no cash and free cash flow” necessitates that Maxar “eliminate its dividend immediately, or risk wiping out equity holders.” On this news, Maxar’s share price fell more than 13% on August 7, 2018, thereby injuring investors.

Then, on January 7, 2019, Maxar disclosed that WorldView-4 had experienced a failure in its CMGs, preventing the satellite from collecting imagery due to the loss of an axis of stability. On this news, the Company’s stock price fell $5.69 per share, or 48.5%, over the following two trading sessions, to close at $6.03 on January 8, 2019.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased shares of Maxar, you may move the Court no later than March 15, 2019 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay and Murray LLP, Los Angeles

Lesley Portnoy, 310-201-9150 or 888-773-9224

www.glancylaw.com

shareholders@glancylaw.com

GPM Logo.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
13 Mar
 
Skam dig selv. Jeg synes faktisk dit udsagn er urimeligt. Vedkommende har i god tro købt lidt aktier..
15
12 Mar
DANSKE
Finans bringer i dag en liste over de højest gagerede bankfolk i EU   5000 tjener over 1 mio.€ (hera..
15
18 Mar
GOMX
SAS's emmision overtegnet så de regner med 15MUSD i provenu samlet - godt nyt for GOMSpace hvis de k..
14
14 Mar
BA
Elliot.Blot for info så har jeg cirka 14.000 timer på 737 serien og der er altid problemer når en ty..
14
14 Mar
DANSKE
Danske Bank er sværd at værdiansætte set i forhold til den situation som Danske Bank befinder sig i...
12
13 Mar
ZEAL
Der er nogle enkelt punkter som jeg har noteret mig under læsningen af Årsrapporten 2018 samt de sen..
12
18 Mar
BAVA
For mig virker det ret underligt at udmelding fra FDA om ydereligere 3mdr mere behandlingstid bliver..
11
15 Mar
PNDORA
Det forhold, at Pandora på trods af negativ analyse fra Carnegie og udbetaling af udbytte har holdt ..
11
13 Mar
VELO
https://www.marketwatch.com/press-release/organ-transplantation-market-to-ascent-exponentially-at-98..
11
12 Mar
NOVO-B
Novo er nu tæt på et pas på område for de kortsigetede. Så jeg vil være OBS på, om købssignalerne æn..
11

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
HPV Vaccine Mandate Ill-Advised, States Association of American Physicians and Surgeons (AAPS)
2
AzurRx BioPharma Announces Presentation on Its Positive Phase II Data in MS1819-SD in Chronic Pancreatitis at the 2019 Digestive Disease Week Conference
3
Jumio Partners with ComplyAdvantage to Reduce AML Risk Exposure
4
Global Gaming’s X2 Games Announces the Launch of Pre-Orders for its Cutting-Edge Amazon Alexa Powered Board Game St. Noire
5
BOXX Showcases Data Science Workstation and Other Solutions at GTC

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 March 2019 10:41:49
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20190215.1 - EUROWEB3 - 2019-03-19 11:41:49 - 2019-03-19 10:41:49 - 1000 - Website: OKAY